Trade ImmuCell - ICCC CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.12 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023346% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001124% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 5.41 |
| Open | 5.38 |
| 1-Year Change | 7.17% |
| Day's Range | 5.38 - 5.45 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 24, 2025 | 5.41 | 0.14 | 2.66% | 5.27 | 5.48 | 5.27 |
| Apr 23, 2025 | 5.41 | 0.03 | 0.56% | 5.38 | 5.42 | 5.38 |
| Apr 22, 2025 | 5.38 | 0.00 | 0.00% | 5.38 | 5.47 | 5.29 |
| Apr 21, 2025 | 5.36 | 0.01 | 0.19% | 5.35 | 5.46 | 5.34 |
| Apr 17, 2025 | 5.40 | 0.08 | 1.50% | 5.32 | 5.43 | 5.28 |
| Apr 16, 2025 | 5.30 | 0.00 | 0.00% | 5.30 | 5.44 | 5.18 |
| Apr 15, 2025 | 5.32 | 0.14 | 2.70% | 5.18 | 5.45 | 5.18 |
| Apr 14, 2025 | 5.35 | -0.07 | -1.29% | 5.42 | 5.44 | 5.06 |
| Apr 11, 2025 | 5.19 | 0.18 | 3.59% | 5.01 | 5.38 | 5.01 |
| Apr 10, 2025 | 5.02 | -0.39 | -7.21% | 5.41 | 5.41 | 4.79 |
| Apr 9, 2025 | 4.60 | -0.24 | -4.96% | 4.84 | 4.84 | 4.60 |
| Apr 8, 2025 | 4.77 | -0.50 | -9.49% | 5.27 | 5.30 | 4.74 |
| Apr 7, 2025 | 5.13 | -0.12 | -2.29% | 5.25 | 5.25 | 5.10 |
| Apr 4, 2025 | 5.34 | 0.00 | 0.00% | 5.34 | 5.44 | 5.28 |
| Apr 3, 2025 | 5.35 | 0.05 | 0.94% | 5.30 | 5.55 | 5.23 |
| Apr 2, 2025 | 5.31 | 0.41 | 8.37% | 4.90 | 5.44 | 4.90 |
| Apr 1, 2025 | 4.95 | 0.03 | 0.61% | 4.92 | 5.36 | 4.89 |
| Mar 31, 2025 | 4.77 | -0.17 | -3.44% | 4.94 | 4.95 | 4.75 |
| Mar 28, 2025 | 4.98 | 0.34 | 7.33% | 4.64 | 5.01 | 4.58 |
| Mar 27, 2025 | 4.70 | -0.04 | -0.84% | 4.74 | 5.00 | 4.49 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
ImmuCell Company profile
About ImmuCell Corporation
ImmuCell Corporation is an animal health company. The Company is engaged in development, acquisition, manufacture and sale of products that improve the health and productivity of dairy and beef cattle. It manufactures and markets the First Defense product line for the prevention of scours in newborn dairy and beef calves. It expanded this line into five different products with formulations targeting E. coli and coronavirus pathogens as well as E. coli, coronavirus and rotavirus pathogens. Its Tri-Shield First Defense product line extension is calf-level, passive antibody product providing immediate immunity against E. coli, coronavirus and rotavirus. These product line provides Immediate Immunity to newborn calves. The Company is engaged in development of Re-Tain, a Nisin treatment for subclinical mastitis in lactating dairy cows. Its products reduce the use of traditional antibiotics in food producing animals.
Financial summary
BRIEF: For the nine months ended 30 September 2021, ImmuCell Corporation revenues increased 19% to $13.8M. Net loss decreased 87% to $152K. Revenues reflect First Defense® product line segment increase of 44% to $9.5M, Other animal health segment increase of 83% to $186K, United States segment increase of 18% to $12.2M, Others segment increase of 28% to $1.6M.
Equity composition
Common Stock $.10 Par, 12/10, 8M auth., 3,261,148 issd., less 287,496 shs. in Treas. @ $635K. Insiders own 26.70%. PO 5/87, 966,000 Units (100 Common + 5 Warrants) @ $7/Unit by Stuart James. 7/90, 1-for-100 reverse stock split.
| Industry: | Biotechnology & Medical Research (NEC) |
56 Evergreen Drive
PORTLAND
MAINE 04103
US
News
ECB interest-rate forecasts – Projections for the next five years
The European Central Bank (ECB) plays a pivotal role in the economic stability of the eurozone, meaning ECB interest-rate forecasts are key to understanding how financial and economic scenarios might evolve.
14:37, 10 April 2025
BlackRock shareholders: Who owns the most BLK stock?
BlackRock is the leading asset manager in the world – but who are its biggest shareholders? Read on to find out.
13:46, 9 April 2025
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
10:28, 9 April 2025
Tesla (TSLA) stock forecast 2025 and beyond: third-party Tesla price target
Where will Tesla’s stock be in five years? Can the EV company keep its crown?
08:19, 9 April 2025
JasmyCoin price predictions 2025-2030: Third-party price target
How might JASMY behave in the future?
16:13, 8 April 2025
Australian interest-rate projections: where will rates be in 5 years?
As one of the most closely watched economic indicators, Australian interest-rate projections offer valuable insight into the future of the country’s economy.
21:37, 7 April 2025
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025People also watch
Still looking for a broker you can trust?
Join the 720,000+ traders worldwide that chose to trade with Capital.com